XW043F5 Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach...
ICD-10-PCS Procedure Codes
The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products:
The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. |
XW043F5 Structure
| X | Section | New Technology |
| W | Body System | Anatomical Regions |
| 0 | Operation | Introduction |
| 4 | Body Part | Central Vein |
| 3 | Approach | Percutaneous |
| F | Device / Substance / Technology | Other New Technology Therapeutic Substance |
| 5 | Qualifier | New Technology Group 5 |
XW0 Section Table
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|---|---|---|---|
| 1 Subcutaneous Tissue | 3 Percutaneous | 1 Eladocagene exuparvovec | 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | L Paclitaxel-Coated Balloon Technology, Four or More Balloons 2 CPI-601 Enzyme Replacement Therapy | 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 4 Stem Cells, Somatic | 8 New Technology Group 8 C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 6 Landiolol Antiarrhythmic | A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | F Valoctocogene Roxaparvovec-rvox | 5 New Technology Group 5 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | G Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System H Paclitaxel-Coated Balloon Technology, One Balloon K Paclitaxel-Coated Balloon Technology, Three Balloons U COVID-19 Vaccine | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | S Iobenguane I-131 Antineoplastic | 6 New Technology Group 6 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | T Melphalan Hydrochloride Antineoplastic | 6 New Technology Group 6 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | V Xanomeline and Trospium Chloride | 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | W AGN1 Bone Void Filler | 5 New Technology Group 5 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 2 Muscle | 0 Open | D Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension | 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 2 Muscle | 3 Percutaneous | S Iobenguane I-131 Antineoplastic T Melphalan Hydrochloride Antineoplastic U COVID-19 Vaccine | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 2 Muscle | 3 Percutaneous | V Xanomeline and Trospium Chloride W AGN1 Bone Void Filler Y Other New Technology Monoclonal Antibody | 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 0 Alpha1-proteinase Inhibitor | 8 New Technology Group 8 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 1 Eladocagene exuparvovec | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | D Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension 3 Lunsotogene Parvec-cwha via Intracochlear Infusion 4 Stem Cells, Somatic | A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 5 Ifezuntirgene Inilparvovec | 7 New Technology Group 7 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 6 Landiolol Antiarrhythmic | 8 New Technology Group 8 C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 7 Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy | 2 New Technology Group 2 8 New Technology Group 8 C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 8 Mineral-based Topical Hemostatic Agent | 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 9 Odronextamab Antineoplastic | 6 New Technology Group 6 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | A Ciltacabtagene Autoleucel J Paclitaxel-Coated Balloon Technology, Two Balloons | 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | B Vancomycin-eluting Bone Void Filler | 3 New Technology Group 3 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | C Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold M Baricitinib N SER-109 | 7 New Technology Group 7 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | E Remdesivir Anti-infective S Iobenguane I-131 Antineoplastic | 5 New Technology Group 5 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | F Valoctocogene Roxaparvovec-rvox | 3 New Technology Group 3 5 New Technology Group 5 A New Technology Group 10 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | G Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System H Paclitaxel-Coated Balloon Technology, One Balloon | 5 New Technology Group 5 6 New Technology Group 6 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | K Paclitaxel-Coated Balloon Technology, Three Balloons | 7 New Technology Group 7 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | L Paclitaxel-Coated Balloon Technology, Four or More Balloons | 6 New Technology Group 6 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | P Gentamicin-eluting Bone Void Filler R Letetresgene Autoleucel | 9 New Technology Group 9 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | Q Iloprost | 5 New Technology Group 5 9 New Technology Group 9 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | W AGN1 Bone Void Filler | 5 New Technology Group 5 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 0 Alpha1-proteinase Inhibitor | 8 New Technology Group 8 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 1 Eladocagene exuparvovec | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 3 Lunsotogene Parvec-cwha via Intracochlear Infusion 4 Stem Cells, Somatic | A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 5 Ifezuntirgene Inilparvovec | 7 New Technology Group 7 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 6 Landiolol Antiarrhythmic | 8 New Technology Group 8 C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 7 Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy | 2 New Technology Group 2 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 8 Mineral-based Topical Hemostatic Agent | 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | 9 Odronextamab Antineoplastic | 6 New Technology Group 6 8 New Technology Group 8 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | A Ciltacabtagene Autoleucel J Paclitaxel-Coated Balloon Technology, Two Balloons | 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | B Vancomycin-eluting Bone Void Filler | 3 New Technology Group 3 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | C Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold M Baricitinib N SER-109 | 7 New Technology Group 7 A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | E Remdesivir Anti-infective S Iobenguane I-131 Antineoplastic | 5 New Technology Group 5 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | F Valoctocogene Roxaparvovec-rvox | 3 New Technology Group 3 5 New Technology Group 5 A New Technology Group 10 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | G Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System H Paclitaxel-Coated Balloon Technology, One Balloon | 5 New Technology Group 5 6 New Technology Group 6 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | K Paclitaxel-Coated Balloon Technology, Three Balloons | 7 New Technology Group 7 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | L Paclitaxel-Coated Balloon Technology, Four or More Balloons | 6 New Technology Group 6 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | P Gentamicin-eluting Bone Void Filler R Letetresgene Autoleucel | 9 New Technology Group 9 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | Q Iloprost | 5 New Technology Group 5 9 New Technology Group 9 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 4 Central Vein | 3 Percutaneous | W AGN1 Bone Void Filler | 5 New Technology Group 5 B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 5 Peripheral Artery | 3 Percutaneous | 4 Stem Cells, Somatic | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 5 Peripheral Artery | 3 Percutaneous | T Melphalan Hydrochloride Antineoplastic | 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| 6 Cerebral Ventricle | 3 Percutaneous | 2 CPI-601 Enzyme Replacement Therapy | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | K Paclitaxel-Coated Balloon Technology, Three Balloons 3 Lunsotogene Parvec-cwha via Intracochlear Infusion | 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | 8 Mineral-based Topical Hemostatic Agent | 2 New Technology Group 2 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | F Valoctocogene Roxaparvovec-rvox | 5 New Technology Group 5 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | J Paclitaxel-Coated Balloon Technology, Two Balloons N SER-109 | 9 New Technology Group 9 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | M Baricitinib | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| D Mouth and Pharynx | X External | V Xanomeline and Trospium Chloride | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| E Ear(s) | 3 Percutaneous | 3 Lunsotogene Parvec-cwha via Intracochlear Infusion | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| G Upper GI | 7 Via Natural or Artificial Opening | K Paclitaxel-Coated Balloon Technology, Three Balloons 3 Lunsotogene Parvec-cwha via Intracochlear Infusion | 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| G Upper GI | 7 Via Natural or Artificial Opening | M Baricitinib | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| G Upper GI | 8 Via Natural or Artificial Opening Endoscopic | 8 Mineral-based Topical Hemostatic Agent | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| H Lower GI | 7 Via Natural or Artificial Opening | K Paclitaxel-Coated Balloon Technology, Three Balloons X Peptide Enhanced Bone Void Filler 3 Lunsotogene Parvec-cwha via Intracochlear Infusion | 8 New Technology Group 8 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| H Lower GI | 7 Via Natural or Artificial Opening | M Baricitinib | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| H Lower GI | 8 Via Natural or Artificial Opening Endoscopic | 8 Mineral-based Topical Hemostatic Agent | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| J Coronary Artery, One Artery K Coronary Artery, Two Arteries L Coronary Artery, Three Arteries M Coronary Artery, Four or More Arteries | 3 Percutaneous | H Paclitaxel-Coated Balloon Technology, One Balloon J Paclitaxel-Coated Balloon Technology, Two Balloons K Paclitaxel-Coated Balloon Technology, Three Balloons L Paclitaxel-Coated Balloon Technology, Four or More Balloons | A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| Q Cranial Cavity and Brain | 3 Percutaneous | 1 Eladocagene exuparvovec | 6 New Technology Group 6 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| Q Cranial Cavity and Brain | 3 Percutaneous | 5 Ifezuntirgene Inilparvovec | C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| U Joints | 0 Open | C Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold | C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| U Joints | 0 Open | G Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System | A New Technology Group 10 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| U Joints | 0 Open | X Peptide Enhanced Bone Void Filler | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| U Joints | 3 Percutaneous 4 Percutaneous Endoscopic | X Peptide Enhanced Bone Void Filler | B New Technology Group 11 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| V Bones | 0 Open | B Vancomycin-eluting Bone Void Filler | C New Technology Group 12 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| V Bones | 0 Open | P Gentamicin-eluting Bone Void Filler | 7 New Technology Group 7 |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
| V Bones | 3 Percutaneous | W AGN1 Bone Void Filler | A New Technology Group 10 |
Additional Code Information includes:
Access to this feature is available in the following products:
|
ICD-10-PCS Index Entries (Reverse Index Lookup) 
reverse_index/reverse_index_content.php?set=ICD10PCS&c=XW043F5
View historical information about the code including when it was added, changed, deleted, etc. Access to this feature is available in the following products:
|
Subscribers may add their own notes as well as "Admin Notes" visible to all subscribers in their account. Access to this feature is available in the following products:
Subscribers may add their own notes as well as "Admin Notes" visible to all subscribers in their account. |
Subscribers will see related documentation, coding and billing tips. Access to this feature is available in the following products:
|
View the general equivalency mappings (GEMs) between the ICD-9 and ICD-10 code sets. Access to this feature is available in the following products:
|
Cross-A-Code™ (ICD-9/10, CPT, Modifiers, NCCI, NDC, ASA CROSSWALK®)
crosswalks/crosswalk_content.php?set=ICD10PCS&c=XW043F5
View relationships (or crosswalks) between code sets. Access to this feature is available in the following products:
|
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Aimee - AI-powered coding assistant
Would you like Aimee - AIto help you with this?
Quick, Current, Complete - www.findacode.com
